Berocca. The company is investing in geographical expansion to strengthen its presence in
the U.S. Brazil, Russia, and China through marketing innovations and novel digital
offerings. For instance, the company introduced a number of new product line extensions
in the U.S. of its existing brands, including ClariSpray in the Claritin portfolio added in
April, 2016. The extension of Alka-Seltzer product family with the addition of Alka-
Seltzer Plus as an OTC medicine for treatment of cold. Successful strategic
implementation and new product development by the company is expected to significantly
affect the growth of global over-the-counter drugs market.
4. Sanofi - Sanofi is a global life science company based in France (Europe) that is aimed
towards improving healthcare access to people. The company operates its business
through two major segments namely, Pharmaceuticals and Vaccines. The company
operates its over-the-counter business as a part of a major business segment named
Consumer Healthcare (CHC). Sanofi focuses on partnerships and acquisitions to expand its
consumer healthcare business. For instance, Sanofi completed acquisition of Boehringer
Ingelheim’s CHC business in 2017, expand the company’s global footprint and product
portfolio. In February 2017, Sanofi sold 5 of its over-the-counter drugs to Ipsen SA on
closure of its asset swap with Boehringer Ingelheim GmbH. Ipsen SA was entitled for a
payment of US$ 98.70 million to purchase the deal from Sanofi. The total revenue of the
company’s consumer healthcare segment was valued at US$ 4,141.31 million in 2016.
The company reported of good performance and growing sales in developing regions such
as New Zealand and Australia. The major brands in the company’s OTC segment include
Allegra, Doliprane, Essentiale, Nasacort, Maalox, Dorflex, and Lactacyd
To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/
buy-now/1443
The global over-the-counter drugs market is highly competitive, owing to increasing adoption of
personal healthcare and self-medication due to rising awareness among the people regarding
health precautions and basic drug knowledge. Under such conditions, the competitors experience
performance pressure in terms of pricing. Market players are thus focusing on development of
OTC drugs in cost-effective way that will help to cater price-sensitive customers, in turn,
significantly maintain and subsequently increase profit margins, especially in emerging
economies.